News

      October 6, 2021 News

      New Press Article in Svenska Dagbladet

      in the INNOVATIVA FÖRETAG edition - October 2021

      Read more

      October 5, 2021 News

      Nobel Prize 2021 in Physiology or Medicine

      for discoveries of receptors for temperature and touch.

      Read more

      October 4, 2021 News

      Oblique Therapeutics AB (publ). announces that it has reached a key milestone

      in its aKRAS antibody program and achieved validation of its Abiprot® platform.

      Read more

      September 15, 2021 News

      Oblique Therapeutics AB (publ). : one of the 101 Top

      Pharmaceutical Start Ups and Companies to follow in Sweden (2021).

      Read more

      September 3, 2021 Event

      Have you missed Obliques’ presentation

      during the Pareto Securities’ Healthcare Conference 2021?

      Read more

      September 1, 2021 News

      Our Founder & CEO Prof. Owe Orwar has been named a winner

      in the CEO Today Healthcare Awards for 2021 by CEO Today Magazine.

      Read more

      August 30, 2021 Event

      For the 1st Neuropathic Pain Therapeutics Summit

      our Head of Discovery & Preclinical R&D- Ion Channel Target in Pain – Daniela Papadia was invited as Expert Speaker.

      Read more

      June 18, 2021 News

      Annual General Meeting On Wednesday the 15th of June 2021,

      we held our Annual General Meeting to conclude our year and discuss about the future. Exciting time.

      Read more

      April 26, 2021 News

      The prestigious Shanghai ranking gives at Karolinska Institutet

      the fifth position in the world of the best Departments of Pharmacology worldwide.

      Read more

      April 19, 2021 News

      Science Advances, has published a research article

      describing our proteomics technology AbiProt®, a high-tech antibody discovery approach with the potential to bring several novel antibody medicines to large patient populations in multiple disease areas.

      Read more
      1 3 4 5 6 7